[HTML][HTML] Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

HK Al-Hakeim, A Khairi Abed… - Frontiers in Molecular …, 2023 - frontiersin.org
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and
increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …

Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in Long COVID

HK Al-Hakeim, AK Abed, SR Moustafa, AF Almulla… - medRxiv, 2023 - medrxiv.org
Background Critical COVID-19 disease is accompanied by depletion of plasma tryptophan
(TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of …

Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID.

HK Al-Hakeim, AK Abed, SR Moustafa… - Frontiers in …, 2023 - search.ebscohost.com
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and
increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …

[PDF][PDF] Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

HK Al-Hakeim, AK Abed, SR Moustafa, AF Almulla… - 2023 - researchgate.net
After the COVID-19 pandemic, which caused millions of acute cases and millions of deaths,
healthcare professionals are facing another crisis due to the development and/or …

[PDF][PDF] Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

HK Al-Hakeim, AK Abed, SR Moustafa, AF Almulla… - 2023 - scienceopen.com
After the COVID-19 pandemic, which caused millions of acute cases and millions of deaths,
healthcare professionals are facing another crisis due to the development and/or …

Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

HK Al-Hakeim, AK Abed, SR Moustafa… - Frontiers in …, 2023 - search.proquest.com
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and
increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …

Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

HK Al-Hakeim, A Khairi Abed, S Rouf Moustafa… - 2023 - dro.deakin.edu.au
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and
increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …

[HTML][HTML] Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in Long COVID

HK Al-Hakeim, AK Abed, SR Moustafa, AF Almulla… - 2023 - europepmc.org
Background Critical COVID-19 disease is accompanied by depletion of plasma tryptophan
(TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of …

[HTML][HTML] Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

HK Al-Hakeim, AK Abed, SR Moustafa… - Frontiers in Molecular …, 2023 - ncbi.nlm.nih.gov
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and
increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …

Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

HK Al-Hakeim, AK Abed… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and
increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive …